(Trump holds a new COVID-19 test kit developed by Abbott Labs during the daily coronavirus briefing at the Rose Garden of the White House on March 30, 2020 in Washington, DC.) On Monday, The New York Times reported that Donald Trump is personally invested in the medication he has been selling to the American public. The Times stated that, “Mr. Trump himself has a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine.” There was no further detail about the particulars of his investment and as someone who has poured over his financial disclosure from 2019, I can only assume that the ownership is contained within one of the several trusts he reported that has not been further broken down by name or stock.
We sent an email to with a link to finish logging in.